Relationships among body composition, muscle strength, and sarcopenia in esophageal squamous cell carcinoma patients

被引:12
作者
Sugawara, Kotaro [1 ]
Yamashita, Hiroharu [1 ]
Okumura, Yasuhiro [1 ]
Yagi, Koichi [1 ]
Yoshimura, Shuntaro [1 ]
Kawasaki, Koichiro [1 ]
Tanabe, Asami [1 ]
Aikou, Susumu [1 ,2 ]
Seto, Yasuyuki [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Gastrointestinal Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Bariatr & Metab Care, Tokyo, Japan
关键词
Esophageal squamous cell carcinoma; Body mass index; Skeletal muscle mass; Muscle strength; Sarcopenia; QUALITY-OF-LIFE; MASS INDEX; CANCER; ASSOCIATION; OUTCOMES; CHEMOTHERAPY; PREVALENCE; SURVIVAL; OBESITY; IMPACT;
D O I
10.1007/s00520-019-05110-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Relationships among body composition indices assessed by various modalities remain to be addressed in patients with esophageal squamous cell carcinoma (ESCC), in whom being underweight is more strikingly prevalent than in those with other malignancies. We investigated the relationships of body composition parameters with the sarcopenia prevalence of ESCC patients. Methods In this prospective study, we analyzed preoperative data obtained from 75 ESCC patients undergoing esophagectomy. Body composition data included body mass index (BMI), skeletal muscle index (SMI) assessed by computed tomography, and parameters calculated by bioelectrical impedance analysis (skeletal muscle mass (SMM), body fat mass). Muscle strength was evaluated by handgrip strength (HGS). Sarcopenia was defined as having both low SMI and low HGS. Results The median BMI value was 22.5 (range 15.2-28.7) in our ESCC cohort. BMI correlated significantly with fat mass (r = 0.84, P < 0.001), SMM (r = 0.57, P < 0.001) and SMI (r = 0.49, P < 0.001). Similarly, SMI showed a significant correlation with SMM (r = 0.45, P < 0.001). Meanwhile, HGS was highly correlated with SMM (r = 0.67, P < 0.001), while showing significant but weak associations with both BMI and SMI (r = 0.33, 0.34, respectively, P < 0.001). Notably, sarcopenia prevalence differed markedly according to BMI category; 28.6%, 12.2%, and 0% in the low (< 20), medium (20-25), and high (> 25) BMI groups, respectively. Conclusions BMI reflects comprehensive information on body composition in ESCC patients, although its correlation with muscle mass and muscle strength was moderate. Decreased BMI might serve as an indicator for sarcopenia in this population, in which the presence of sarcopenic obesity is rare.
引用
收藏
页码:2797 / 2803
页数:7
相关论文
共 39 条
  • [1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
    AARONSON, NK
    AHMEDZAI, S
    BERGMAN, B
    BULLINGER, M
    CULL, A
    DUEZ, NJ
    FILIBERTI, A
    FLECHTNER, H
    FLEISHMAN, SB
    DEHAES, JCJM
    KAASA, S
    KLEE, M
    OSOBA, D
    RAZAVI, D
    ROFE, PB
    SCHRAUB, S
    SNEEUW, K
    SULLIVAN, M
    TAKEDA, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 365 - 376
  • [2] [Anonymous], 2019, Surg Endosc
  • [3] [Anonymous], 2001 EORTC QLQ C30 S
  • [4] Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy
    Baracos, V. E.
    Arribas, L.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 1 - 9
  • [5] Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer
    Blazeby, JM
    Conroy, T
    Hammerlid, E
    Fayers, P
    Sezer, O
    Koller, M
    Arraras, J
    Bottomley, A
    Vickery, CW
    Etienne, PL
    Alderson, D
    [J]. EUROPEAN JOURNAL OF CANCER, 2003, 39 (10) : 1384 - 1394
  • [6] Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis
    Boshier, P. R.
    Heneghan, R.
    Markar, S. R.
    Baracos, V. E.
    Low, D. E.
    [J]. DISEASES OF THE ESOPHAGUS, 2018, 31 (08)
  • [7] The evolution of body composition in oncology-epidemiology, clinical trials, and the future of patient care: facts and numbers
    Brown, Justin C.
    Feliciano, Elizabeth M. Cespedes
    Caan, Bette J.
    [J]. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2018, 9 (07) : 1200 - 1208
  • [8] Muscle mass and association to quality of life in non-small cell lung cancer patients
    Bye, Asta
    Sjoblom, Bjorg
    Wentzel-Larsen, Tore
    Gronberg, Bjorn H.
    Baracos, Vickie E.
    Hjermstad, Marianne J.
    Aass, Nina
    Bremnes, Roy M.
    Flotten, Oystein
    Jordhoy, Marit
    [J]. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2017, 8 (05) : 759 - 767
  • [9] Age-dependent prognostic value of body mass index for non-metastatic clear cell renal cell carcinoma: A large multicenter retrospective analysis
    Byun, Seok-Soo
    Hwang, Eu C.
    Kang, Seok H.
    Hong, Sung-Hoo
    Chung, Jinsoo
    Kwon, Tae G.
    Kim, Hyeon H.
    Kwak, Cheol
    Kim, Yong-June
    Lee, Won K.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2018, 118 (01) : 199 - 205
  • [10] Current technologies in body composition assessment: advantages and disadvantages
    Ceniccola, Guilherme Duprat
    Castro, Melina Gouveia
    Fraga Piovacari, Silvia Maria
    Horie, Lilian Mika
    Correa, Fabiano Girade
    Noronha Barrere, Ana Paula
    Toledo, Diogo Oliveira
    [J]. NUTRITION, 2019, 62 : 25 - 31